Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In most cases, people with type 2 diabetes can drink alcohol in moderate amounts. As you may well know, living with type 2 diabetes often means cutting out or cutting back on foods and beverages that ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

The latest to join the ranks is the so-called “natural Mounjaro” drink for weight loss. Recipes vary slightly depending on which one you find, but the natural Mounjaro drink generally consists of ...

"The landmark 10-year, 1,440-person Diabetes Control and Complications Trial (DCCT), published in 1993, established hemoglobin A1c as the gold standard for evaluating the risk for complications ...

The company attributed the revision to lower-than-expected sales of tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity. “It’s always disappointing to miss your own ...

Incretins such as glucagon-like peptide-1, or GLP-1, are used in diabetes and obesity drugs like Eli Lilly's Mounjaro and Zepbound. The stock (LLY) dropped 8.2% in morning trading, enough to make ...

One jab that's been capturing public attention and headlines lately is Mounjaro. The Labour Party unveiled plans to introduce the weight-loss jab Mounjaro on the NHS in England in December ...

Eli Lilly’s expectations for sales in the fourth quarter of last year missed forecasts, driven by lower-than-expected sales of its diabetes and obesity drugs Mounjaro and Zepbound. This is ...